This November's BIGMEDX Strategy Brief examines the escalating regulatory pressures that will shape the MedTech industry in 2026. From FDA's new QMSR reforms to global AI governance, supply-chain risks, and emerging-market challenges, this issue breaks down what companies must prepare for as compliance becomes the core driver of global expansion.

By BIGMEDX Strategy Brief Series October 2025 Borders are tightening, tariffs are rising, and compliance rules are shifting. Yet global demand for medical technology is not slowing; it’s accelerating. For MedTech innovators, the question is no longer whether  to expand internationally but how quickly  they can align strategy with execution. At BIGMEDX , our September briefing made the case that expansion is no longer optio